Antibiotic Prescribing Pattern in Patients with Diabetes Mellitus Complications in Panembahan Senopati Bantul Hospital

Authors

  • Eva Nurjanah Pharmacy Study Program, Faculty of Health Sciences, Universitas Alma Ata Yogyakarta, DIY Yogyakarta 55184, Indonesia ,
  • Daru Estiningsih Pharmacy Study Program, Faculty of Health Sciences, Universitas Alma Ata Yogyakarta, DIY Yogyakarta 55184, Indonesia ,
  • Nurul Kusumawardani Pharmacy Study Program, Faculty of Health Sciences, Universitas Alma Ata Yogyakarta, DIY Yogyakarta 55184, Indonesia ,
  • Ninisita Sri Hadi General Hospital (RSUP) Dr. Sardjito, DIY Yogyakarta 55281, Indonesia ,

DOI:

https://doi.org/10.35814/jifi.v21i1.1150

Keywords:

Antibiotics, comorbidities, complications, diabetes mellitus, infection

Abstract

Diabetes Mellitus, one of the non-communicable diseases (NCDs), is the leading cause of death in addition to cardiovascular disease, cancer, and chronic respiratory disease. The Basic Health Research (Riskesdas) recorded that Yogyakarta experienced a prevalence increase of 97% in 2013-2018, the second-highest in Indonesia. Uncontrolled sugar levels cause deterioration of the immune system. This study aims to determine the pattern of prescribing antibiotics and the occurrence of comorbid complications, both infectious and non-infectious. This was a non-experimental descriptive study with a cross-sectional design. The data was collected from patient's medical records retrospectively from July to December 2019. Furthermore, 65 medical records were taken using a simple random sampling method. A descriptive statistical analysis was performed, and the results were presented as percentages. The percentage of infectious and non-infectious comorbid diabetes mellitus II in Panembahan Senopati Bantul Hospital was 22.2% and 77.8%, respectively. The prescribing pattern primarily used was ceftriaxone (23.5%). The antibiotic class mainly prescribed was cephalosporin (49%).

References

Downloads

Published

2023-04-29

Issue

Vol. 21 No. 1 (2023): JIFI

Section

Articles

License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.